文献速递白血病淋巴瘤

SHMT抑制在T细胞急性淋巴细胞白血病中有效并与甲氨蝶呤协同

SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia.
PubMed 文献 · Leukemia · 2020-05-07

研究报道SHMT抑制剂SHIN2通过13C-丝氨酸示踪证实体内靶点结合。SHIN2延长NOTCH1驱动的小鼠原代T-ALL生存,低剂量甲氨蝶呤使Molt4人T-ALL细胞对SHIN2敏感,体外甲氨蝶呤耐药细胞对SHIN2敏感性增强。SHIN2与甲氨蝶呤在小鼠原代T-ALL及人源患者来源异种移植中协同延长生存。

要点

  • SHIN2抑制SHMT并延长NOTCH1驱动小鼠原代T-ALL的生存。
  • 低剂量甲氨蝶呤使Molt4人T-ALL细胞对SHIN2敏感。
  • SHIN2与甲氨蝶呤在小鼠原代T-ALL和人源异种移植中协同延长生存。

核心结论

  • SHMT抑制为T-ALL治疗提供了一种互补策略。

研究设计与样本

  • 研究使用SHMT抑制剂SHIN2,以13C-丝氨酸示踪评估体内靶点结合。
  • 在NOTCH1驱动的小鼠原代T-ALL、Molt4人T-ALL细胞、体外甲氨蝶呤耐药细胞及人源患者来源异种移植中评估SHIN2作用。

主要发现

  • SHIN2在NOTCH1驱动的小鼠原代T-ALL体内增加生存。
  • 低剂量甲氨蝶呤使Molt4人T-ALL细胞对SHIN2敏感。
  • 体外诱导的甲氨蝶呤耐药细胞对SHIN2敏感性增强。
  • SHIN2与甲氨蝶呤在小鼠原代T-ALL和人源患者来源异种移植体内协同并增加生存。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Folate metabolism enables cell growth by providing one-carbon (1C) units for nucleotide biosynthesis. The 1C units are carried by tetrahydrofolate, whose production by the enzyme dihydrofolate reductase is targeted by the important anticancer drug methotrexate. 1C units come largely from serine catabolism by the enzyme serine hydroxymethyltransferase (SHMT), whose mitochondrial isoform is strongly upregulated in cancer. Here we report the SHMT inhibitor SHIN2 and demonstrate its in vivo target engagement with 13C-serine tracing. As methotrexate is standard treatment for T-cell acute lymphoblastic leukemia (T-ALL), we explored the utility of SHIN2 in this disease. SHIN2 increases survival in NOTCH1-driven mouse primary T-ALL in vivo. Low dose methotrexate sensitizes Molt4 human T-ALL cells to SHIN2, and cells rendered methotrexate resistant in vitro show enhanced sensitivity to SHIN2. Finally, SHIN2 and methotrexate synergize in mouse primary T-ALL and in a human patient-derived xenograft in vivo, increasing survival. Thus, SHMT inhibition offers a complementary strategy in the treatment of T-ALL.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. García-Cañaveras JC, Lancho O, Ducker GS, et al. SHMT inhibition is effective and synergizes with methotrexate in T-cell acute lymphoblastic leukemia. Leukemia. 2020. PMID: 32382081. doi:10.1038/s41375-020-0845-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。